Counselling patients on inhalers and respiratory medicines

Pharmacists sit at the frontline of respiratory care across Australia, where roughly one in nine people lives with asthma and chronic obstructive pulmonary disease remains a leading cause of avoidable hospital admission. Every dispense of a reliever or preventer puffer is a chance to revisit technique, reinforce adherence and catch the small mistakes that quietly inflate exacerbation rates. In pharmacies from Parramatta to Perth, the brief conversation at the counter often makes the difference between a patient who controls their condition and one who ends up in the emergency department.

This article walks through the practical elements of inhaler counselling, from the mechanics of pressurised metered-dose devices to age-specific adaptations and the wider care team. It is written for community pharmacists, interns and pharmacy students who want a grounded approach shaped by Australian clinical guidelines, PBS realities and the everyday cadence of community pharmacy practice.

The mechanics behind effective inhaler use

Inhaler technique is rarely a single lesson. It is a sequence of small actions, each of which can drift over months and years of daily puffing. When pharmacists understand the mechanics behind each device, they can deconstruct mistakes rather than simply instructing the patient to try again.

Pressurised metered-dose inhalers (pMDIs) require coordination between actuation and inhalation. Dry powder inhalers (DPIs) depend on sufficient inspiratory flow to disaggregate the dose, while soft mist inhalers produce a slower aerosol that gives patients more time to coordinate. Spacer devices are commonly recommended for pMDIs because they remove the need for hand-breath coordination and increase lung deposition. In paediatric and geriatric cohorts especially, a spacer with a mask can transform a struggling routine into a reliable one.

Breathing pattern matters as much as device choice. Patients should exhale gently to functional residual capacity before placing the mouthpiece between the lips, then inhale slowly and deeply for a pMDI or forcefully and deeply for a DPI. A breath-hold of around ten seconds allows the medicine to settle in the airways, after which the patient breathes out slowly away from the device. Repeating this calmly, with the patient performing each step in front of the pharmacist, exposes the gaps that brochures cannot.

Common errors pharmacists should watch for

Watching a patient use their inhaler in real time, rather than asking whether they use it correctly, is the single highest-yield intervention a pharmacist can offer. Self-reported technique is notoriously unreliable, and most errors go unnoticed for years.

The most frequent mistakes include failing to shake a suspension pMDI before use, not exhaling before inhalation, actuating the inhaler too early or too late during the inhalation, and forgetting to hold the breath long enough. With dry powder devices, patients often exhale into the mouthpiece, which can dampen the powder and clog the mechanism. They also frequently load the dose but then pause, losing the impulse needed to inhale forcefully. Corticosteroid-containing inhalers should always be followed by a rinse and spit of the mouth to reduce the risk of oral thrush and dysphonia, a step that many long-term users admit to skipping.

A simple teach-back approach, where the patient demonstrates their routine while the pharmacist observes, allows these issues to surface and be corrected in a non-judgemental way. Repeating the demonstration at the next dispense, even briefly, builds the muscle memory that turns a corrected technique into a habit. A short note in the dispensing profile flags the issue for the next pharmacist on the bench.

Asthma and COPD in the Australian context

Australian respiratory care is shaped by a few distinctive realities. The National Asthma Council Australia publishes the Australian Asthma Handbook, which is the country's primary clinical reference and is updated regularly. Asthma Australia, the national peak body, runs community education campaigns and produces consumer resources that pharmacists can point patients towards. Inhaler technique is a recurring theme in their work because national audits continue to show that a majority of patients demonstrate at least one critical error.

The Pharmaceutical Benefits Scheme underwrites the cost of most preventer and reliever therapy, which keeps medicines affordable and means pharmacists are often the clinicians with the most frequent touchpoints. Combination inhalers containing an inhaled corticosteroid and a long-acting beta-agonist have become first-line preventer therapy for many patients, and newer soft mist and breath-actuated devices are increasingly listed. PBS listings change, so staying across the latest schedule helps pharmacists counsel on cost as well as technique.

Climate and environment also matter. During bushfire season, particularly in New South Wales and Victoria, air quality can deteriorate rapidly and patients on preventer therapy may need reminders to use their reliever more frequently or to follow the written asthma action plan they developed with their GP. Thunderstorm asthma events in spring, well documented across the south-eastern states, remain a genuine risk that pharmacists can flag when dispensing preventers in late September and October.

Adherence, synchronisation and refill management

Even with perfect technique, an inhaler only works when it is actually in the patient's hand. Adherence to preventer therapy in asthma and COPD remains stubbornly low, with many patients using their preventer intermittently and relying on a reliever that, by definition, indicates poor control. Pharmacists can address this through routine conversations, dose administration aids and structured follow-up.

Medication synchronisation, where all of a patient's regular medicines are aligned to a single monthly dispense date, reduces the cognitive load of managing multiple scripts and improves refill persistence. The benefits of these programmes for patients with chronic disease are well documented, including in why medication synchronisation matters for adherence. Where a community pharmacy offers a synchronisation service, asking whether a patient on combination inhaler therapy is also managing other chronic scripts creates a natural opening to enrol them.

MedsCheck and Diabetes MedsCheck consultations provide funded time to sit down with patients, walk through every inhaler and spacer, and reconcile what is in the bag with what is on the record. Storing these notes in the dispensing profile means the next pharmacist who serves the patient can build on the conversation rather than start from scratch. For Aboriginal and Torres Strait Islander patients, the Quality Use of Medicines Maximised program supports longer, more thorough reviews that respect cultural context and family decision-making around medicines.

Tailoring counselling across the lifespan

Children, adults and older patients each bring different needs to the consultation bench. A good pharmacist reads the room and adapts the conversation accordingly.

For pre-school children, the focus is usually on the parent or carer. A pMDI with a spacer and mask is typically the device of choice, and the pharmacist should watch the carer fit the mask, count the breaths and check that the child is tolerating the seal. Older children can move to a mouthpiece spacer, and many can transition to a DPI once they can demonstrate reliable inspiratory flow, often around age six or seven. School-aged patients may feel more confident with a device that does not draw attention, and adolescents benefit from being addressed directly rather than through a parent, with honest conversations about vaping and smoking.

For older adults, dexterity, vision and cognition all matter. Arthritis can make loading a DPI difficult; tremor can complicate actuation; and cognitive impairment may interfere with multi-step routines. Large-volume spacers reduce the need for perfect coordination, while simple once-daily regimens are easier to sustain. Carers and family members should be included in the conversation when appropriate, and written action plans with large, clear print help prevent confusion during an exacerbation.

Aboriginal and Torres Strait Islander patients experience higher rates of hospitalisation for respiratory illness and benefit from longer reviews, the involvement of an Aboriginal health worker, and culturally safe spaces for chronic disease management. Pharmacists working in rural and remote communities often coordinate with visiting respiratory nurses and telehealth services to make sure follow-up does not depend solely on the patient's ability to return to the pharmacy.

Collaborative care and patient education resources

Respiratory outcomes improve when pharmacists work alongside GPs, practice nurses, respiratory physicians and asthma educators rather than in isolation. The written asthma action plan, usually developed with the GP, anchors the shared approach, and the pharmacist is often the one who explains how each step on the plan maps to a specific inhaler.

Patient education increasingly happens online as well as at the counter, and pharmacists can guide patients away from unreliable sources. Many consumers now use search engines to research their inhalers, side effects and newer therapies, and understanding how readers search for health information helps frame the kind of conversations pharmacists have when correcting misinformation. Pointing patients to resources such as the National Asthma Council, Asthma Australia and the Lung Foundation Australia keeps the advice evidence-based and aligned with local guidelines.

Following up after a hospital discharge for a respiratory admission is another high-value moment. A quick call or text to check on inhaler technique, spacer use and action plan confidence can prevent readmission, and several community pharmacies in Australia have built this into their routine workflow with the support of local Primary Health Networks. For pharmacists interested in structured reflection on their own practice, the Johnathan Laird blog is a useful place to read about adherence programmes, inhaler reviews and broader community pharmacy initiatives.

A practical inhaler checklist to share with patients

• Shake the pMDI for five seconds before use, remove the cap and breathe out gently away from the mouthpiece.
• Seal lips around the mouthpiece, press the canister once and breathe in slowly and deeply for a pMDI, or forcefully and deeply for a DPI.
• Hold the breath for around ten seconds, then breathe out slowly away from the device.
• Repeat the dose as prescribed and rinse the mouth with water and spit after any corticosteroid-containing inhaler.

Australian referral and support pathways

• National Asthma Council Australia for clinical guidelines, written action plan templates and device demonstration videos.
• Asthma Australia and the Lung Foundation Australia for consumer-friendly education and local support programs.
• State-based Asthma Foundations and Primary Health Networks for community workshops and clinical updates.
• Local Aboriginal Community Controlled Health Organisations and Aboriginal health workers for culturally safe respiratory reviews.

To embed inhaler counselling into a structured service, book a MedsCheck or asthma-focused review with one or two patients each week, practise the teach-back method and document the findings in the dispensing profile. Refine the routine with your team and use the Australian Asthma Handbook as your reference. Subscribe to the blog for more practical pharmacy content and patient counselling strategies, and add a brief inhaler check-in to every relevant dispense this week.